GLP-1 drug use surges, along with coverage costs for employers

Published July 20, 2026 3:00 PM EDT Updated July 21, 2026 12:05 PM EDT 4 Min Read

Wegovy semaglutide injection pen with medication package — Adobe Stock

Key Insight: Learn why employee use of GLP-1 weight-loss drugs has nearly quadrupled since 2024.
What’s at Stake: Employers risk losing key talent or facing unsustainable health coverage costs.
Supporting Data: 11% of U.S. adults currently take GLP-1 medications for weight loss.
Source: Bullets generated by AI with editorial review

Americans are using GLP-1 weight-loss drugs at a record pace, with Gallup finding that use has nearly quadrupled since 2024, putting pressure on employers to find sustainable ways to cover the medications.

Jimmy Nesbitt

Reporter

Jimmy Nesbitt is a reporter at Employee Benefit News, where he covers the evolving landscape of workplace benefits, healthcare, retirement, financial wellness and related policy issues. His career … Read full bio

For reprint and licensing requests for this article, click here.

More From Employee Benefit News

Healthcare

With healthcare costs jumping 9%, employers are shifting strategy

Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.

By Jimmy Nesbitt

Reporter

Employee Benefits News

August 28

Medical stethoscope resting on brown insurance clipboard near laptop, highlighting healthcare expenses and medical documentation process.

Benefits Think Predictive analytics become essential as high-cost claimants surge

As costs to treat serious conditions surge, employers must plan how to absorb budget-altering expenses ahead of time.

August 25

Katherine Shanahan

Healthcare

How procurement services can lighten healthcare spend

Bringing a procurement partner into the benefits planning process can offer greater insight and negotiation power, helping to reduce overall costs.

By Lee Hafner

Editor

Employee Benefit News

August 21

Group of employees sitting at table, talking

Benefits Think Healthcare costs are rising. Here’s how brokers can help employers respond

Gap coverage, supplemental benefits and options for various types of workers can help avoid cost shifting and still provide support.

August 21

Chris Berggren

Healthcare

Employers face a new GLP-1 question: Are the drugs worth it?

As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.

By Jimmy Nesbitt

Reporter

Employee Benefits News

August 19

GLP-1 Coverage: Are Employers Getting a Return?